Synergistic induction of matrix metalloproteinase 1 by interleukin-1α and oncostatin M in human chondrocytes involves signal transducer and activator of transcription and activator protein 1 transcription factors via a novel mechanism

Arthritis and Rheumatism

Volumn 44, Issue 10, 2001, Pages 2296-2310

  Catterall, J B ^a,c   Carrere S ^a   Koshy, P J T ^a   Degnan, B A ^a   Shingleton, W D ^a   Brinckerhoff, C E ^b   Rutter, J ^b   Cawston, T E ^a   Rowan, A D ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1ALPHA; INTERSTITIAL COLLAGENASE; LUCIFERASE; ONCOSTATIN M; RECEPTOR; STAT1 PROTEIN; STAT3 PROTEIN; TRANSCRIPTION FACTOR AP 1;

ARTICLE; CARTILAGE CELL; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; FLOW CYTOMETRY; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE INDUCTION; HUMAN; HUMAN CELL; NORTHERN BLOTTING; ONCOGENE C FOS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SITE DIRECTED MUTAGENESIS;

CELL LINE, TRANSFORMED; CHONDROCYTES; DNA-BINDING PROTEINS; DRUG SYNERGISM; HUMANS; INTERLEUKIN-1; MATRIX METALLOPROTEINASE 1; ONCOSTATIN M; PEPTIDES; PROTO-ONCOGENE PROTEINS C-FOS; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSCRIPTION FACTOR AP-1;

EID: 0034761792     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200110)44:10<2296::AID-ART392>3.0.CO;2-9     Document Type: Article

References (74)

1. Matrix metalloproteinases and TIMPs: Properties and implications for the rheumatic diseases
2. Cloning and characterization of ADAMTS11, an aggrecanase from the ADAMTS family
3. Purification and cloning of aggrecanase-1: A member of the ADAMTS family of proteins
4. In vivo studies of cartilage regeneration after damage induced by catabolin/interleukin-1
5. The breakdown of collagen by chondrocytes
6. Human skin collagenase: Isolation of precursor and active forms from both fibroblast and organ cultures
7. Human neutrophil collagenase: A distinct gene product with homology to other matrix metalloproteinases
8. Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas
9. Comparative immunolocalization studies of collagenase 1 and collagenase 3 production in the rheumatoid lesion, and by human chondrocytes and synoviocytes in vitro
10. Matrix metalloproteinase 13 (collagenase 3) in human rheumatoid synovium
11. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage
12. Collagenase-1 and collagenase-3 synthesis in normal and early experimental osteoarthritic canine cartilage: An immunohistochemical study
13. The measurement of collagenase, tissue inhibitor of metalloproteinases (TIMP), and collagenase-TIMP complex in synovial fluids from patients with osteoarthritis and rheumatoid arthritis
14. Joint destruction in arthritis: Metalloproteinases in the spotlight
15. Pig catabolin is a form of interleukin 1: Cartilage and bone resorb, fibroblasts make prostaglandin and collagenase, and thymocyte proliferation is augmented in response to one protein
16. Synovial fluid concentration of five different cytokines in rheumatic diseases
17. Interleukin-1 and oncostatin M in combination promote the release of collagen fragments from bovine nasal cartilage in culture
18. The role of oncostatin M in animal and human connective tissue collagen turnover and its localization within the rheumatoid joint
19. The synovial expression and serum levels of interleukin-6, interleukin-11, leukemia inhibitory factor, and oncostatin M in rheumatoid arthritis
20. Synergistic effects of glycoprotein 130 binding cytokines in combination with interleukin-1 on cartilage collagen breakdown
21. Serum levels of interleukin-6 type cytokines and soluble interleukin-6 receptor in patients with rheumatoid arthritis
22. Interleukin-6 (IL-6) induces the proliferation of synovial fibroblastic cells in the presence of soluble IL-6 receptor
23. Interleukin 6 levels in synovial fluids of patients with different arthritides: Correlation with local IgM rheumatoid factor and systemic acute phase protein production
24. Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides
25. Selective regulation of metalloproteinase inhibitor (TIMP-1) by oncostatin M in fibroblasts in culture
26. Interleukin (IL)-6 and its soluble receptor induce TIMP-1 expression in synoviocytes and chondrocytes, and block IL-1-induced collagenolytic activity
27. Dual oncostatin M (OSM) receptors: Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation
28. STATs: Signal transducers and activators of transcription
29. Gp130 and the interleukin-6 family of cytokines
30. Identification of the interleukin-6/oncostatin M response element in the rat tissue inhibitor of metalloproteinases-1 (TIMP-1) promoter
31. The mitogen-activated protein kinase and JAK-STAT signaling pathways are required for an oncostatin M-responsive element-mediated activation of matrix metalloproteinase 1 gene expression
32. Direct evidence of high DNA binding activity of transcription factor AP-1 in rheumatoid arthritis synovium
33. Synovial fibroblast-like cells strongly express jun-B and C-fos proto-oncogenes in rheumatoid and osteoarthritis
34. Spontaneous expression of immediately early response genes c-fos and egr-1 in collagenase-producing rheumatoid synovial fibroblasts
35. AP-1 and NF-kappaB regulation in rheumatoid arthritis and murine collageninduced arthritis
36. The AP-1 site and MMP gene regulation: What is all the fuss about?
37. Studies on the contribution of c-fos/AP-1 to arthritic joint destruction
38. Signal transduction and transcription factors in rheumatic disease
39. Regulation of the balance of cytokine production and the signal transducer and activator of transcription (STAT) transcription factor activity by cytokines and inflammatory synovial fluids
40. Cytokines and the Jak-STAT signaling pathway in inflammatory arthritis
41. Towards an understanding of the signal transduction pathways for interleukin 1
42. The interleukin-1 receptor accessory protein (IL-1RAcP) is essential for IL-1-induced activation of interleukin-1 receptor-associated kinase (IRAK) and stress-activated protein kinases (SAP kinases)
43. Signal transduction pathways activated by the IL-1 receptor family: Ancient signaling machinery in mammals, insects, and plants
44. Activation of the MAP kinase subgroups JNK and p38 is selectively associated with IL-1 or TNF stimulation of human articular chondrocytes
45. The interactions of the cytokine-binding homology region and immunoglobulin-like domains of gp130 with oncostatin M: Implications for receptor complex formation
46. The crystal structure and biological function of leukemia inhibitory factor: Implications for receptor binding
47. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family
48. Cell-type specific regulation of human interstitial collagenase-1 gene expression by interleukin-1β (IL-1β) in human fibroblasts and BC-8701 breast cancer cells
49. Roles of JAKs in activation of STATs and stimulation of c-fos gene expression by epidermal growth factor
50. Overexpression of the FosB2 gene in thymocytes causes aberrant development of T cells and thymic epithelial cells
51. Specific inhibition of Stat3 signal transduction by PIAS3
52. Interleukin-1β-modulated gene expression in immortalized human chondrocytes
53. Oncostatin M stimulates c-fos to bind a transcriptionally responsive AP-1 element within the tissue inhibitor of metalloproteinase-1 promoter
54. Selective extraction of polyoma DNA from infected mouse cell cultures
55. MatInd and MatInspector: New fast and versatile tools for detection of consensus matches in nucleotide sequence data
56. The interleukin-1 receptor in normal and osteoarthritic human articular chondrocytes: Identification as the type 1 receptor and analysis of binding kinetics and biologic function
57. Differential activation of c-fos promoter elements by serum, lysophosphatidic acid, G-proteins and polypeptide growth factors
58. The possible role of c-fos expression in rheumatoid cartilage destruction
59. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway
60. Isolation and characterization of the human gp130 promoter: Regulation by STATS
61. Modulation of interleukin-1 receptor expression by transforming growth factor-beta in cultured rabbit articular chondrocytes: Analysis by reverse transcription-polymerase chain reaction
62. Differential modulation of degradative and repair responses of interleukin-1 treated chondrocytes by platelet-derived growth factor
63. Induction of interleukin-1 receptors on chondrocytes by fibroblast growth factor: A possible mechanism for modulation of interleukin-1 activity
64. A critical role for interleukin-1 receptor accessory protein in interleukin-1 signaling
65. Osteoclasts in normal and adjuvant arthritis bone tissues express the mRNA for both type I and II interleukin-1 receptors
66. STAT protein complexes activated by interferon-gamma and gp130 signaling molecules differ in their sequence preferences and transcriptional induction properties
67. Regulation of collagenase gene expression by IL-1β requires transcriptional and post-transcriptional mechanisms
68. Two activator protein-1 elements in the matrix metalloproteinase-1 promoter have different effects on transcription and bind Jun D, c-Fos, and Fra-2
69. Interleukin-1 beta induction of c-fos and collagenase expression in articular chondrocytes: Involvement of reactive oxygen species
70. IL-6-inducible complexes on an IL-6 response element of the junB promoter contain Stat3 and 36 kDa CRE-like site binding protein(s)
71. Interleukin-6 increases rat metalloproteinase-13 gene expression through stimulation of activator protein 1 transcription factor in cultured fibroblasts
72. Interleukin-6 and leukemia inhibitory factor induction of JunB is regulated by distinct cell type-specific cis-acting elements
73. Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor κB: Differential regulation of collagenase 1 and collagenase 3
74. Transcriptional cross-talk, the second mode of steroid hormone receptor action